D
PharmaCyte Biotech, Inc. PMCB
$1.04 $0.032.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -35.79% -14.64% -51.66% -23.96% -40.49%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -33.15% -10.66% -48.62% -21.47% -38.86%
Operating Income 33.15% 10.66% 48.62% 21.47% 38.86%
Income Before Tax -135.69% 772.47% -391.57% -152.68% 835.76%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -135.69% 772.47% -391.57% -152.68% 835.76%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -135.69% 772.47% -391.57% -152.68% 835.76%
EBIT 33.15% 10.66% 48.62% 21.47% 38.86%
EBITDA -- -- -- -- --
EPS Basic -164.70% 620.15% 33.00% 17.82% 453.70%
Normalized Basic EPS -692.39% -138.40% 720.00% 15.03% 153.26%
EPS Diluted -164.70% 620.15% 33.00% 17.82% 453.70%
Normalized Diluted EPS -692.39% -138.40% 720.00% 15.03% 153.26%
Average Basic Shares Outstanding -13.61% -17.91% -19.14% -12.87% -37.58%
Average Diluted Shares Outstanding -13.61% -17.91% -19.14% -12.87% -37.58%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --